Extensions for Using Data Elements from FHIR R5 in FHIR STU3
0.1.0 - STU
Extensions for Using Data Elements from FHIR R5 in FHIR STU3
0.1.0 - STU
Extensions for Using Data Elements from FHIR R5 in FHIR STU3 - Downloaded Version null See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R5-v3-VaccineManufacturer-for-R3 | Version: 0.1.0 | |||
| Standards status: Trial-use | Maturity Level: 0 | Computable Name: R5V3VaccineManufacturerForR3 | ||
This cross-version ValueSet represents content from http://terminology.hl7.org/ValueSet/v3-VaccineManufacturer|2.0.0 for use in FHIR STU3.
This value set is part of the cross-version definitions generated to enable use of the
value set http://terminology.hl7.org/ValueSet/v3-VaccineManufacturer|2.0.0 as defined in FHIR R5
in FHIR STU3.
The source value set is bound to the following FHIR R5 elements:
Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
FHIR ValueSet http://terminology.hl7.org/ValueSet/v3-VaccineManufacturer|2.0.0, defined in FHIR R5 does not have any mapping to FHIR STU3
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer version 📍2.1.0| Code | Display |
| AB | Abbott Laboratories (includes Ross Products Division) |
| AD | Adams Laboratories |
| ALP | Alpha Therapeutic Corporation |
| AR | Armour [Inactive - use CEN] |
| AVI | Aviron |
| BA | Baxter Healthcare Corporation |
| BAY | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) |
| BP | Berna Products [Inactive - use BPC] |
| BPC | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) |
| CEN | Centeon L.L.C. (includes Armour Pharmaceutical Company) |
| CHI | Chiron Corporation |
| CON | Connaught [Inactive - use PMC] |
| EVN | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) |
| GRE | Greer Laboratories, Inc. |
| IAG | Immuno International AG |
| IM | Merieux [Inactive - use PMC] |
| IUS | Immuno-U.S., Inc. |
| JPN | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) |
| KGC | Korea Green Cross Corporation |
| LED | Lederle [Inactive - use WAL] |
| MA | Massachusetts Public Health Biologic Laboratories |
| MED | MedImmune, Inc. |
| MIL | Miles [Inactive - use BAY] |
| MIP | Bioport Corporation (formerly Michigan Biologic Products Institute) |
| MSD | Merck and Co., Inc. |
| NAB | NABI (formerly North American Biologicals, Inc.) |
| NAV | North American Vaccine, Inc. |
| NOV | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) |
| NYB | New York Blood Center |
| ORT | Ortho Diagnostic Systems, Inc. |
| OTC | Organon Teknika Corporation |
| PD | Parkedale Pharmaceuticals (formerly Parke-Davis) |
| PMC | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) |
| PRX | Praxis Biologics [Inactive - use WAL] |
| SCL | Sclavo, Inc. |
| SI | Swiss Serum and Vaccine Inst. [Inactive - use BPC] |
| SKB | SmithKline Beecham |
| USA | United States Army Medical Research and Materiel Command |
| WA | Wyeth-Ayerst [Inactive - use WAL] |
| WAL | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) |
This value set expansion contains 40 concepts.
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r5.r3#0.1.0 based on FHIR 3.0.2. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change